The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System
Recruiting
N/A
Interventional Study
OMI - Occlusion Myocardial Infarction
Artificial Intelligence (AI)
Electrocardiogram
Cost-effectiveness Analysis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 212,000 (estimated)
- Sponsor
- National Defense Medical Center, Taiwan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients in the emergency department
* Patients received at least 1 ECG examination.
Exclusion Criteria:
* The patients received ECG at the period of inactive AI-ECG system.
* Patients with a history of coronary angiography within the past 3 days.
Contacts